Overexpression of anti-apoptotic proteins such as Bcl-2, Bcl-XL, and Mcl-1 has been associated with drug resistance in human tumor cell lines (10–12), including NHL cells (13–16). This evidence concerns the gene BCL2 and non-Hodgkin lymphoma.